Biphasic insulin aspart 30 three times daily is more effective than a twice- daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on OADs Wenying Yang, PhD 1 , Qiuhe Ji, PhD 2 , Dalong Zhu, PhD 3 , Jinkui Yang, PhD 4 , Lulu Chen, PhD 5 , Zhimin Liu, MSc 6 , Demin Yu, PhD 7 , Li Yan, MSc 8 1 China-Japan Friendship Hospital, Dept. Endocrinology, Beijing, China 2 The Xijing Hospital affiliated to 4th Military Medical University, Dept. Endocrinology, Xi'an, China 3 The Nanjing Drum Tower Hospital, Dept. Endocrinology, Nanjing, China 4 The Beijing Tongren Hospital, Dept. Endocrinology, Beijing, China 5 The Wuhan Union Hospital, Dept. Endocrinology, Wuhan, China 6 The Shanghai Changzheng Hospital, Dept. Endocrinology, Shanghai, China 7 The Metabolic Disease Hospital affiliated to Tianjin Medical University, Dept. Endocrinology, Tianjin, China 8 Sun Yixian Commemorative Hospital affiliated to Zhongshan University, Dept. Endocrinology, Guangzhou, China Running Title: TID BIAsp 30 in Chinese type 2 diabetes subjects Corresponding Author: Professor Wenying Yang, China-Japan Friendship Hospital, Department of Endocrinology, Beijing, China yangwenying1707@yahoo.com.cn Clinical Trial Registry No. NCT00184561 Received for publication 15 October 2007 and accepted din revised form 31 January 2008. Diabetes Care Publish Ahead of Print, published online February 11, 2008 Copyright American Diabetes Association, Inc., 2008 ©